0001209191-16-139142.txt : 20160830 0001209191-16-139142.hdr.sgml : 20160830 20160830163814 ACCESSION NUMBER: 0001209191-16-139142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160826 FILED AS OF DATE: 20160830 DATE AS OF CHANGE: 20160830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DNIB UNWIND, INC. CENTRAL INDEX KEY: 0001385228 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174913400 MAIL ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: BIND Therapeutics, Inc DATE OF NAME CHANGE: 20130612 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences, Inc DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences Inc DATE OF NAME CHANGE: 20070105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36072 FILM NUMBER: 161861050 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-26 0 0001385228 DNIB UNWIND, INC. BIND 0001177082 LYNCH DANIEL C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET CAMBRIDGE MA 02139 1 0 0 1 Chairman Common Stock 2016-08-26 4 M 0 20000 0.44 A 20000 D Employee Stock Option (Right to Buy) 0.44 2016-08-26 4 M 0 20000 0.00 D 2026-06-20 Common Stock 20000 0 D This option became fully vested and exercisable as a result of the sale of substantially all of the assets of DNIB Unwind, Inc. (f/k/a BIND Therapeutics, Inc.) (the "Company") on August 1, 2016 (the "Sale"). The Sale constituted a Change in Control (as defined in the Company's 2013 Incentive Award Plan). /s/ Daniel Lynch 2016-08-30